Clinical trial
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
NCT00077597 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00077597 |
|---|---|
| Title | A Study of Mircera for the Treatment of Anemia in Dialysis Patients |
| Official title | A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | epoetin, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 182 |
| Start date | Feb 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Feb 12, 2004 |
| Last update posted | Nov 2, 2016 |
| Countries | Brazil, Canada, Czechia, Greece, Norway, Poland, Russia, South Africa, Spain, Sweden, Switzerland, Thailand and 1 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: